GLENMARK
Invest with MTF
Invest Now
Invest in Glenmark Pharmaceuticals with 3.43X leverage
Performance
- Low
- ₹2,005
- High
- ₹2,048
- 52 Week Low
- ₹1,276
- 52 Week High
- ₹2,285
- Open Price₹2,034
- Previous Close₹2,035
- Volume241,750
- 50 DMA₹1,977.96
- 100 DMA₹1,952.07
- 200 DMA₹1,865.89
Investment Returns
- Over 1 Month + 1.08%
- Over 3 Month + 10.36%
- Over 6 Month -0.92%
- Over 1 Year + 45.02%
Smart Investing Starts Here Start SIP with Glenmark Pharmaceuticals for Steady Growth!
Glenmark Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 54
- PEG Ratio
- 0.1
- Market Cap Cr
- 57,546
- P/B Ratio
- 6
- Average True Range
- 56.75
- EPS
- 95.92
- Dividend Yield
- 0.2
- MACD Signal
- -6.77
- RSI
- 57.25
- MFI
- 40.66
Glenmark Pharmaceuticals Financials
Glenmark Pharmaceuticals Technicals
EMA & SMA
Current Price
₹2,039.20
+
4.7
(0.23%)
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹1,982.92
- 50 Day
- ₹1,977.96
- 100 Day
- ₹1,952.07
- 200 Day
- ₹1,865.89
Resistance and Support
2024.87
- R3 2,086.53
- R2 2,062.77
- R1 2,048.63
- S1 2,010.73
- S2 1,986.97
- S3 1,972.83
Glenmark Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Glenmark Pharmaceuticals F&O
About Glenmark Pharmaceuticals
- NSE Symbol
- GLENMARK
- BSE Symbol
- 532296
- Chairman & Managing Director
- Mr. Glenn Saldanha
- ISIN
- INE935A01035
Similar Stocks to Glenmark Pharmaceuticals
Glenmark Pharmaceuticals FAQs
Glenmark Pharmaceuticals share price is ₹2,039 As on 13 February, 2026 | 11:19
The Market Cap of Glenmark Pharmaceuticals is ₹57546.4 Cr As on 13 February, 2026 | 11:19
The P/E ratio of Glenmark Pharmaceuticals is 54 As on 13 February, 2026 | 11:19
The PB ratio of Glenmark Pharmaceuticals is 6 As on 13 February, 2026 | 11:19
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.